Researchers from Peking University (PKU) recently presented the discovery and preclinical evaluation of a novel small-molecule inhibitor of pan-αv integrin, C19-9-21, being developed for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback